BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18545234)

  • 1. Poor prognosis osteosarcoma: new therapeutic approach.
    Fagioli F; Biasin E; Mereuta OM; Muraro M; Luksch R; Ferrari S; Aglietta M; Madon E
    Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S131-4. PubMed ID: 18545234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary bone osteosarcoma in the pediatric age: state of the art.
    Longhi A; Errani C; De Paolis M; Mercuri M; Bacci G
    Cancer Treat Rev; 2006 Oct; 32(6):423-36. PubMed ID: 16860938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
    Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
    J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.
    Toporski J; Garkavij M; Tennvall J; Ora I; Gleisner KS; Dykes JH; Lenhoff S; Juliusson G; Scheding S; Turkiewicz D; Békássy AN
    Biol Blood Marrow Transplant; 2009 Sep; 15(9):1077-85. PubMed ID: 19660720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tandem high-dose chemotherapy followed by autologous transplantation in patients with locally advanced or metastatic sarcoma.
    Lashkari A; Chow WA; Valdes F; Leong L; Phan V; Twardowski P; Kapoor N; Molina A; Al-Kadhimi Z; Frankel P; Somlo G
    Anticancer Res; 2009 Aug; 29(8):3281-8. PubMed ID: 19661346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteosarcoma treatment: state of the art.
    Ta HT; Dass CR; Choong PF; Dunstan DE
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):247-63. PubMed ID: 19214708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
    Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
    Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 28 years of high-dose therapy and SCT for neuroblastoma in Europe: lessons from more than 4000 procedures.
    Ladenstein R; Pötschger U; Hartman O; Pearson AD; Klingebiel T; Castel V; Yaniv I; Demirer T; Dini G;
    Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S118-27. PubMed ID: 18545256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.
    Butturini AM; Jacob M; Aguajo J; Vander-Walde NA; Villablanca J; Jubran R; Erdreich-Epstein A; Marachelian A; Dhall G; Finlay JL
    Cancer; 2009 Jul; 115(13):2956-63. PubMed ID: 19402050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radical surgery and intensive chemotherapy are necessary for successful treatment of osteosarcoma].
    Kruseová J; Mottl H; Kodet R; Mrácek J; Matejovský Zm; Schovanec J; Snajdauf J; Rygl M; Lisková I; Kabítková E; Malis J; Sumerauer D; Drahokoupilová E; Ganevová M; Smelhaus V; Starý J
    Klin Onkol; 2009; 22(4):168-75. PubMed ID: 19731879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation.
    Inamoto Y; Kurahashi S; Imahashi N; Fukushima N; Adachi T; Kinoshita T; Tsushita K; Miyamura K; Naoe T; Sugiura I
    Am J Hematol; 2009 May; 84(5):283-6. PubMed ID: 19338045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a role for immunotherapy in osteosarcoma?
    Loeb DM
    Cancer Treat Res; 2009; 152():447-57. PubMed ID: 20213407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome after polychemotherapy and intensive local radiation therapy of high-grade osteosarcoma.
    Hundsdoerfer P; Albrecht M; Rühl U; Fengler R; Kulozik AE; Henze G
    Eur J Cancer; 2009 Sep; 45(14):2447-51. PubMed ID: 19596190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of spinal osteosarcoma with radiation and chemotherapy.
    Hershey A; Bos GD; Stevens K
    Orthopedics; 1996 Jul; 19(7):617-8. PubMed ID: 8823822
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prognostic factors for 72 patients with osteosarcoma of the extremity treated with neoadjuvant chemotherapy].
    Liu J; Guo W; Yang RL; Tang XD; Yang Y
    Zhonghua Wai Ke Za Zhi; 2008 Aug; 46(15):1166-70. PubMed ID: 19094683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteosarcoma: basic science and clinical implications.
    Hayden JB; Hoang BH
    Orthop Clin North Am; 2006 Jan; 37(1):1-7. PubMed ID: 16311106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria--a population-based report of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group.
    Reismüller B; Attarbaschi A; Peters C; Dworzak MN; Pötschger U; Urban C; Fink FM; Meister B; Schmitt K; Dieckmann K; Henze G; Haas OA; Gadner H; Mann G;
    Br J Haematol; 2009 Feb; 144(4):559-70. PubMed ID: 19077160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the pretransplantation phase of the hemopoietic stem cell program in a tertiary hospital.
    Márquez Malaver FJ; Espigado Tocino I; Balsalobre López P; Carmona González M; Parody Ruiz-Berdejo R; Perez-Hurtado de Mendoza JM; Urbano Ispizua A
    Transplant Proc; 2008 Nov; 40(9):3099-101. PubMed ID: 19010206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase 2 trial of two courses of cyclophosphamide and etoposide for relapsed high-risk osteosarcoma patients.
    Berger M; Grignani G; Ferrari S; Biasin E; Brach del Prever A; Aliberti S; Saglio F; Aglietta M; Fagioli F
    Cancer; 2009 Jul; 115(13):2980-7. PubMed ID: 19452540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.